Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis
This study was based on the preparation, characterization, and animal in vivo experiments performed to evaluate nanoparticles of poly(ɛ-caprolactone) (PCL) and chitosan as carriers of enoxaparin. The nanoparticles were characterized and presented satisfactory results in terms of size, polydispersity...
Saved in:
Main Authors: | Lucas Bessa Prado, Stephany Cares Huber, Aline Barnabé, Fernanda Dutra Santiago Bassora, Devanira Souza Paixão, Nelson Duran, Joyce Maria Annichino-Bizzacchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Nanotechnology |
Online Access: | http://dx.doi.org/10.1155/2017/4925495 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PCL/PHBV Microparticles as Innovative Carriers for Oral Controlled Release of Manidipine Dihydrochloride
by: Fernanda Malaquias Barboza, et al.
Published: (2014-01-01) -
Controlled Release of Ropivacaine from Single-Armed (1-PCL) and Four-Armed PCL (4-PCL) Microspheres
by: Wei Xiong, et al.
Published: (2019-01-01) -
Dry Needling and Antithrombotic Drugs
by: María Muñoz, et al.
Published: (2022-01-01) -
Enoxaparin Effect on Pregnancy Outcomes in a Patient with Elevated Plasminogen Activator Inhibitor-1
by: Kathleen Minor, et al.
Published: (2020-01-01) -
Weight-based enoxaparin thromboprophylaxis in young trauma patients: analysis of the CLOTT-1 registry
by: Sarah Lombardo, et al.
Published: (2024-07-01)